Literature DB >> 33899543

Cytokinesis regulators as potential diagnostic and therapeutic biomarkers for human hepatocellular carcinoma.

Yiting Qiao1, Yunxin Pei2,3, Miao Luo2,3, Muthukumar Rajasekaran4, Kam M Hui2,3,4,5,6,7, Jianxiang Chen2,3,4.   

Abstract

Cytokinesis, the final step of mitosis, is critical for maintaining the ploidy level of cells. Cytokinesis is a complex, highly regulated process and its failure can lead to genetic instability and apoptosis, contributing to the development of cancer. Human hepatocellular carcinoma is often accompanied by a high frequency of aneuploidy and the DNA ploidy pattern observed in human hepatocellular carcinoma results mostly from impairments in cytokinesis. Many key regulators of cytokinesis are abnormally expressed in human hepatocellular carcinoma, and their expression levels are often correlated with patient prognosis. Moreover, preclinical studies have demonstrated that the inhibition of key cytokinesis regulators can suppress the growth of human hepatocellular carcinoma. Here, we provide an overview of the current understanding of the signaling networks regulating cytokinesis, the key cytokinesis regulators involved in the initiation and development of human hepatocellular carcinoma, and their applications as potential diagnostic and therapeutic biomarkers.

Entities:  

Keywords:  Hepatocellular carcinoma; cytokinesis; therapeutic targets

Mesh:

Substances:

Year:  2021        PMID: 33899543      PMCID: PMC8243214          DOI: 10.1177/15353702211008380

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  146 in total

1.  RhoA-kinase coordinates F-actin organization and myosin II activity during semaphorin-3A-induced axon retraction.

Authors:  Gianluca Gallo
Journal:  J Cell Sci       Date:  2006-08-15       Impact factor: 5.285

Review 2.  Centrosomes and cancer: how cancer cells divide with too many centrosomes.

Authors:  Susana A Godinho; Mijung Kwon; David Pellman
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 3.  Molecular control of animal cell cytokinesis.

Authors:  Juan Pablo Fededa; Daniel W Gerlich
Journal:  Nat Cell Biol       Date:  2012-05-02       Impact factor: 28.824

4.  KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis.

Authors:  Isabelle Gasnereau; Mathieu Boissan; Germain Margall-Ducos; Gabrielle Couchy; Dominique Wendum; Florence Bourgain-Guglielmetti; Chantal Desdouets; Marie-Lise Lacombe; Jessica Zucman-Rossi; Joëlle Sobczak-Thépot
Journal:  Am J Pathol       Date:  2011-11-01       Impact factor: 4.307

Review 5.  Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Omar Massoud; Michael Charlton
Journal:  Clin Liver Dis       Date:  2018-02       Impact factor: 6.126

6.  Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.

Authors:  Xiangxuan Zhao; Olorunseun O Ogunwobi; Chen Liu
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.752

Review 7.  Etoposide, topoisomerase II and cancer.

Authors:  E L Baldwin; N Osheroff
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-07

8.  Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma.

Authors:  Haisen Yin; Risheng Que; Chunying Liu; Weidan Ji; Bin Sun; Xuejing Lin; Qin Zhang; Xinying Zhao; Zhangxiao Peng; Xiaofeng Zhang; Haihua Qian; Lei Chen; Yonggang Yao; Changqing Su
Journal:  Cancer Lett       Date:  2018-03-30       Impact factor: 8.679

9.  Targeting Aurora B to the equatorial cortex by MKlp2 is required for cytokinesis.

Authors:  Mayumi Kitagawa; Suet Yin Sarah Fung; Nobuyuki Onishi; Hideyuki Saya; Sang Hyun Lee
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

10.  Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma.

Authors:  Xinran Liu; Yangkai Li; Lijing Meng; Xin-Yuan Liu; Anlin Peng; Yuchen Chen; Chengyu Liu; Hong Chen; Sheng Sun; Xiaoping Miao; Yu Zhang; Ling Zheng; Kun Huang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more
  1 in total

Review 1.  Role of motor proteins in human cancers.

Authors:  Iman Hassan Ibrahim; Amany Balah; Abrar Gomaa Abd Elfattah Hassan; Heba Gamal Abd El-Aziz
Journal:  Saudi J Biol Sci       Date:  2022-09-06       Impact factor: 4.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.